Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo and Active-Controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and With Metformin Plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
Brief Summary: The purpose of this study is to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes


Options:
A: Arm Label: Lira 0.6 + Met; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: metformin, Drug: placebo | Arm Label: Lira 1.2 + Met; Type: EXPERIMENTAL; Interventions: Drug: metformin, Drug: placebo, Drug: liraglutide | Arm Label: Lira 1.8 + Met; Type: EXPERIMENTAL; Interventions: Drug: metformin, Drug: placebo, Drug: liraglutide | Arm Label: Met Mono; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin, Drug: placebo | Arm Label: Met + Glim; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin, Drug: glimepiride, Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 0.6 + Met | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): Lira 0.6 + Met, Lira 1.2 + Met, Lira 1.8 + Met, Met + Glim, Met Mono | Intervention Type: DRUG; Name: glimepiride; Assigned to Arm(s): Met + Glim | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Lira 0.6 + Met, Lira 1.2 + Met, Lira 1.8 + Met, Met Mono | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Met + Glim, Met Mono | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.2 + Met | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.8 + Met
B: Arm Label: Glimepiride; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glimepiride, Drug: Metformin | Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin (JNJ-28431754), Drug: Metformin | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin (JNJ-28431754), Drug: Metformin | Intervention Type: DRUG; Name: Glimepiride; Assigned to Arm(s): Glimepiride | Intervention Type: DRUG; Name: Canagliflozin (JNJ-28431754); Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg, Glimepiride
C: Arm Label: placebo + pioglitazone (with or without metformin); Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: albiglutide + pioglitazone (with or without metformin); Type: EXPERIMENTAL; Interventions: Biological: albiglutide | Intervention Type: BIOLOGICAL; Name: albiglutide; Assigned to Arm(s): albiglutide + pioglitazone (with or without metformin) | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo + pioglitazone (with or without metformin)
D: Arm Label: metformin + glimepiride + pioglitazone + albiglutide placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: placebo to match albiglutide, Drug: metformin, Drug: glimepiride, Drug: pioglitazone | Arm Label: metformin + glimepiride + pioglitazone placebo + albiglutide; Type: EXPERIMENTAL; Interventions: Biological: albiglutide, Drug: metformin, Drug: glimepiride, Drug: placebo to match pioglitazone | Arm Label: met + glimepiride + pioglitazone placebo + albiglutide placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: placebo to match albiglutide, Drug: metformin, Drug: glimepiride, Drug: placebo to match pioglitazone | Intervention Type: DRUG; Name: placebo to match albiglutide; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone + albiglutide placebo | Intervention Type: BIOLOGICAL; Name: albiglutide; Assigned to Arm(s): metformin + glimepiride + pioglitazone placebo + albiglutide | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone + albiglutide placebo, metformin + glimepiride + pioglitazone placebo + albiglutide | Intervention Type: DRUG; Name: glimepiride; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone + albiglutide placebo, metformin + glimepiride + pioglitazone placebo + albiglutide | Intervention Type: DRUG; Name: pioglitazone; Assigned to Arm(s): metformin + glimepiride + pioglitazone + albiglutide placebo | Intervention Type: DRUG; Name: placebo to match pioglitazone; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone placebo + albiglutide

Answer: D